Selective Referral Using CCTA Versus Direct Referral for Individuals Referred to Invasive Coronary Angiography for Suspected CAD: A Randomized, Controlled, Open-Label Trial.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
07 2019
Historique:
received: 15 08 2018
revised: 04 09 2018
accepted: 19 09 2018
pubmed: 17 12 2018
medline: 19 3 2020
entrez: 17 12 2018
Statut: ppublish

Résumé

This study compared the safety and diagnostic yield of a selective referral strategy using coronary computed tomographic angiography (CCTA) compared with a direct referral strategy using invasive coronary angiography (ICA) as the index procedure. Among patients presenting with signs and symptoms suggestive of coronary artery disease (CAD), a sizeable proportion who are referred to ICA do not have a significant, obstructive stenosis. In a multinational, randomized clinical trial of patients referred to ICA for nonemergent indications, a selective referral strategy was compared with a direct referral strategy. The primary endpoint was noninferiority with a multiplicative margin of 1.33 of composite major adverse cardiovascular events (blindly adjudicated death, myocardial infarction, unstable angina, stroke, urgent and/or emergent coronary revascularization or cardiac hospitalization) at a median follow-up of 1-year. At 22 sites, 823 subjects were randomized to a selective referral and 808 to a direct referral strategy. At 1 year, selective referral met the noninferiority margin of 1.33 (p = 0.026) with a similar event rate between the randomized arms of the trial (4.6% vs. 4.6%; hazard ratio: 0.99; 95% confidence interval: 0.66 to 1.47). Following CCTA, only 23% of the selective referral arm went on to ICA, which was a rate lower than that of the direct referral strategy. Coronary revascularization occurred less often in the selective referral group compared with the direct referral to ICA (13% vs. 18%; p < 0.001). Rates of normal ICA were 24.6% in the selective referral arm compared with 61.1% in the direct referral arm of the trial (p < 0.001). In stable patients with suspected CAD who are eligible for ICA, the comparable 1-year major adverse cardiovascular events rates following a selective referral and direct referral strategy suggests that both diagnostic approaches are similarly effective. In the selective referral strategy, the reduced use of ICA was associated with a greater diagnostic yield, which supported the usefulness of CCTA as an efficient and accurate method to guide decisions of ICA performance. (Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization [CONSERVE]; NCT01810198).

Sections du résumé

OBJECTIVES
This study compared the safety and diagnostic yield of a selective referral strategy using coronary computed tomographic angiography (CCTA) compared with a direct referral strategy using invasive coronary angiography (ICA) as the index procedure.
BACKGROUND
Among patients presenting with signs and symptoms suggestive of coronary artery disease (CAD), a sizeable proportion who are referred to ICA do not have a significant, obstructive stenosis.
METHODS
In a multinational, randomized clinical trial of patients referred to ICA for nonemergent indications, a selective referral strategy was compared with a direct referral strategy. The primary endpoint was noninferiority with a multiplicative margin of 1.33 of composite major adverse cardiovascular events (blindly adjudicated death, myocardial infarction, unstable angina, stroke, urgent and/or emergent coronary revascularization or cardiac hospitalization) at a median follow-up of 1-year.
RESULTS
At 22 sites, 823 subjects were randomized to a selective referral and 808 to a direct referral strategy. At 1 year, selective referral met the noninferiority margin of 1.33 (p = 0.026) with a similar event rate between the randomized arms of the trial (4.6% vs. 4.6%; hazard ratio: 0.99; 95% confidence interval: 0.66 to 1.47). Following CCTA, only 23% of the selective referral arm went on to ICA, which was a rate lower than that of the direct referral strategy. Coronary revascularization occurred less often in the selective referral group compared with the direct referral to ICA (13% vs. 18%; p < 0.001). Rates of normal ICA were 24.6% in the selective referral arm compared with 61.1% in the direct referral arm of the trial (p < 0.001).
CONCLUSIONS
In stable patients with suspected CAD who are eligible for ICA, the comparable 1-year major adverse cardiovascular events rates following a selective referral and direct referral strategy suggests that both diagnostic approaches are similarly effective. In the selective referral strategy, the reduced use of ICA was associated with a greater diagnostic yield, which supported the usefulness of CCTA as an efficient and accurate method to guide decisions of ICA performance. (Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization [CONSERVE]; NCT01810198).

Identifiants

pubmed: 30553687
pii: S1936-878X(18)30921-5
doi: 10.1016/j.jcmg.2018.09.018
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01810198']

Types de publication

Comparative Study Journal Article Multicenter Study Pragmatic Clinical Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1303-1312

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Published by Elsevier Inc.

Auteurs

Hyuk-Jae Chang (HJ)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea. Electronic address: hjchang@yuhs.ac.

Fay Y Lin (FY)

Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Dan Gebow (D)

MDDX, San Francisco, California.

Hae Young An (HY)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Ravi Bathina (R)

CARE Hospital and FACTS Foundation, Hyderabad, India.

Andrea Baggiano (A)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Virginia Beltrama (V)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Rodrigo Cerci (R)

Quanta Diagnostico Nuclear, Curitiba, Brazil.

Eui-Young Choi (EY)

Gangnam Severance Hospital, Seoul, South Korea.

Jung-Hyun Choi (JH)

Pusan National University Hospital, Busan, South Korea.

So-Yeon Choi (SY)

Ajou University Hospital, Gyeonggi-do, South Korea.

Namsik Chung (N)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea.

Jason Cole (J)

Cardiology Associates of Mobile, Mobile, Alabama.

Joon-Hyung Doh (JH)

Inje University, Ilsan Paik Hospital, Gyeonggi-do, South Korea.

Sang-Jin Ha (SJ)

Gangneung Asan Hospital, Gangwon-do, South Korea.

Ae-Young Her (AY)

Kangwon National University Hospital, Gangwon-do, South Korea.

Cezary Kepka (C)

Institute of Cardiology, Warsaw, Poland.

Jang-Young Kim (JY)

Wonju Severance Hospital, Gangwon-do, South Korea.

Jin-Won Kim (JW)

Korea University Guro Hospital, Seoul, South Korea.

Sang-Wook Kim (SW)

Chung-Ang University Hospital, Seoul, South Korea.

Woong Kim (W)

Yeungnam University Hospital, Daegu, South Korea.

Gianluca Pontone (G)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Uma Valeti (U)

University of Minnesota, Minneapolis, Minnesota.

Todd C Villines (TC)

Walter Reed Medical Center, Bethesda, Maryland.

Yao Lu (Y)

Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Amit Kumar (A)

Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Iksung Cho (I)

Chung-Ang University Hospital, Seoul, South Korea.

Ibrahim Danad (I)

Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York; VU Medical Center, Amsterdam, the Netherlands.

Donghee Han (D)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea; Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Ran Heo (R)

Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Sang-Eun Lee (SE)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea.

Ji Hyun Lee (JH)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea; Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Hyung-Bok Park (HB)

Myongji Hospital, Seonam University College of Medicine, Gyeonggi-do, South Korea.

Ji-Min Sung (JM)

Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea.

David Leflang (D)

MDDX, San Francisco, California.

Joseph Zullo (J)

MDDX, San Francisco, California.

Leslee J Shaw (LJ)

Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York. Electronic address: https://twitter.com/lesleejshaw.

James K Min (JK)

Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medicine, New York, New York. Electronic address: jkm2001@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH